Skip to content
ChickenStockChickenStock
ResearchRMD
ResMed logo

ResMed (RMD) stock

NYSE

$239.53+0.27%(+0.64)

As of the Nov 13, 2026 close (U.S. Eastern)

Compares the share price with the company's earnings, net assets and sales. Check trading status and financial notes separately.

Price date for the multiples · Nov 13, 2026 · Financial period · Trailing twelve months

P/E and P/S use the latest four quarters where available · P/B uses the latest equity · Computed in-house by ChickenStock

P/E

21.21x

P/B

5.68x

P/S

5.89x

Latest earnings

SEC filings

Jul–Sep 2026(FY2027 Q1)

Revenue increased 5.9% from the same period a year earlier.

Key reported figures come first. Select one to see the same quarter across three years.

See the same quarter across three years →

Filed Oct 30, 2026 · 10-Q · SEC EDGAR

Reported results are from SEC EDGAR filings. Reference information only, not investment advice.

Insider transactions

Recent Form 4 filings grouped by person, date and transaction type.

27 SEC filings
  • Farrell Michael J.Chairman and CEO · Nov 11, 2026Shares withheld for taxes8,111 shares · $1.9M
    Avg. price $234.11
    Show 3 price lots
    • 3,466 shares × $234.11$811K
    • 2,436 shares × $234.11$570K
    • 2,210 shares × $234.11$517K
  • Bloomer AaronChief Financial Officer · Nov 11, 2026Shares withheld for taxes1,095 shares · $256K
    Avg. price $234.117,977 shares held after
  • Rider Michael JGlobal General Counsel · Nov 11, 2026Shares withheld for taxes1,944 shares · $455K
    Avg. price $234.11
    Show 4 price lots
    • 724 shares × $234.11$170K
    • 547 shares × $234.11$128K
    • 499 shares × $234.11$117K
    • 173 shares × $234.11$40K
  • FARRELL PETER CDirector · Nov 11, 2026Shares withheld for taxes169 shares · $40K
    Avg. price $234.1151,634 shares held after
  • De Witte JanDirector · Nov 11, 2026Shares withheld for taxes60 shares · $14K
    Avg. price $234.114,201 shares held after
  • Gill HarjitDirector · Nov 11, 2026Shares withheld for taxes36 shares · $8K
    Avg. price $234.109910,904 shares held after
  • Farrell Michael J.Chairman and CEO · Nov 9, 2026Open-market sale4,993 shares · $1.2M
    Avg. price $235.3473479,803 shares held after
  • Farrell Michael J.Chairman and CEO · Nov 9, 2026Option exercise4,993 shares · $731K
    Avg. price $146.34
    Show 2 price lots
    • 4,310 shares × $146.34$631K
    • 683 shares × $146.34$100K
  • Rider Michael JGlobal General Counsel · Oct 23, 2026Open-market sale400 shares · $102K
    Avg. price $25512,318 shares held after
  • Farrell Michael J.Chairman and CEO · Oct 7, 2026Open-market sale4,991 shares · $1.1M
    Avg. price $226.3349479,803 shares held after
  • Farrell Michael J.Chairman and CEO · Oct 7, 2026Option exercise4,991 shares · $730K
    Avg. price $146.34484,794 shares held after
  • Farrell Michael J.Chairman and CEO · Sep 8, 2026Open-market sale4,991 shares · $1.1M
    Avg. price $222.4385466,256 shares held after
  • Farrell Michael J.Chairman and CEO · Sep 8, 2026Option exercise4,991 shares · $730K
    Avg. price $146.34471,247 shares held after
  • FARRELL PETER CDirector · Sep 2, 2026Open-market sale970 shares · $228K
    Avg. price $234.7351,803 shares held after
  • Farrell Michael J.Chairman and CEO · Aug 14, 2026Grant or award13,547 shares · $0
    Avg. price $0479,803 shares held after
  • Rider Michael JGlobal General Counsel · Aug 14, 2026Grant or award3,230 shares · $0
    Avg. price $012,718 shares held after
  • Leong JustinChief Product Officer · Aug 14, 2026Grant or award6,461 shares · $0
    Avg. price $035,489 shares held after
  • Bloomer AaronChief Financial Officer · Aug 14, 2026Grant or award9,072 shares · $0
    Avg. price $09,072 shares held after
  • Farrell Michael J.Chairman and CEO · Aug 7, 2026Open-market sale4,991 shares · $1.0M
    Avg. price $205.6895466,256 shares held after
  • Farrell Michael J.Chairman and CEO · Aug 7, 2026Option exercise4,991 shares · $730K
    Avg. price $146.34471,247 shares held after
  • FARRELL PETER CDirector · Aug 5, 2026Open-market sale8,000 shares · $1.8M
    Avg. price $22552,773 shares held after

Only transactions reported on SEC Form 4 are shown. A sale may follow a pre-arranged 10b5-1 plan, and items such as option exercises or shares withheld for taxes are not open-market trades.

Recent SEC filings

40 filings

Filings submitted to the U.S. Securities and Exchange Commission (EDGAR). Dates are SEC filing dates (U.S. Eastern). Form and item names are the official SEC titles. The Earnings and Risk tags come directly from form types and item codes; they are not written by AI. Insider ownership reports (Forms 3, 4 and 5) are excluded.

Company overview

Expand ▾

ResMed (RMD) stock information

NYSE

ResMed (RMD) is listed on NYSE. Its market capitalization is about $33.8B. On trailing-twelve-month earnings the P/E ratio is 21.21, and the P/B ratio is 5.68. Return on equity is 26.8%. These figures are computed in-house from official filings and are reference information only.

ResMed — frequently asked questions

What is the P/E ratio of ResMed (RMD)?
On a trailing-twelve-month basis, RMD trades at a P/E ratio of 21.21. It is calculated as market capitalization divided by net income attributable to controlling interests, using official filings. Reference information only.
What is the market capitalization of ResMed?
RMD has a market capitalization of about $33.8B. The figure moves with the share price and is refreshed each trading day.
Does ResMed pay a dividend?
RMD has a dividend yield of about 1%, based on disclosed payment history. Dividend policy can change; this is reference information only.
Is this page investment advice?
No. Every figure on this page is factual reference information compiled from public filings. It is not investment advice, not a price forecast and not a recommendation to buy or sell. Investment decisions rest with the user.

All metrics, scores, and content provided by ChickenStock are reference information derived from market data. They are not investment advice or a solicitation to trade. Investment decisions and their consequences rest with the user.